Reflect Scientific, Inc.

Reflect Scientific, Inc.

RSCF
Reflect Scientific, Inc.US flagOther OTC
0.05
USD
+0.00
- -
4.28MMarket Cap
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
0.05
0.03
0.03
0.03
0.02
0.02
0.02
0.02
0.02
0.03
0.03
0.02
0.01
0.02
Basic EPS, GAAP
-0.03
- -
-0.02
-0.02
0.01
- -
-0.01
- -
- -
0.01
0.01
- -
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.43
-0.4
-0.4
-0.36
-0.32
-0.3
-0.29
-0.26
-0.25
-0.22
-0.21
-0.21
-0.22
-0.21
Tangible Book Value per Share
-0.09
-0.01
-0.01
-0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.03
0.02
0.02
Basic Weighted Avg Shares
42
45
47
54
58
63
66
75
79
85
85
85
85
86
Sales/Revenue/Turnover
2
1
1
2
1
1
1
2
2
3
3
2
1
2
Operating Margin (%)
-30.14
-31.03
-53.11
-47.03
-44.34
-21.17
-37.74
-16.04
-12.11
23.31
29.41
4.41
-43.26
-3.63
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
- -
-1
-1
1
- -
- -
- -
- -
1
1
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.78
- -
0.09
Profit Margin (%)
-59.73
15.12
-78.72
-55.03
80.59
-18.19
-37.74
-16.08
-12.15
23.64
33.36
4.38
-42.5
-1.71
Working Capital
-4
- -
-1
-1
- -
1
- -
- -
- -
1
2
2
2
2
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
-1
1
1
- -
1
1
1
2
2
2
2
Return on Invested Capital (%)
- -
-23.71
- -
- -
-137.7
- -
- -
- -
- -
61.61
43.73
3.85
- -
- -
Return on Capital (%)
- -
-3.2
- -
- -
-4.73
- -
- -
- -
- -
-3.45
-5.13
-0.5
- -
0.46
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
86
86
86
Market Capitalization
6
4
5

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
Total Current Assets
2
2
2
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
- -
- -
- -
Inventories
1
1
1
Total Current Liabilities
1
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.56%
38.72%
-17.59%
Free Cash Flow
-551.64%
-1,005.88%
13.02%
Net Income, GAAP
-141.5%
-224.16%
-613.48%
Sales/Revenue/Turnover
3.99%
0.69%
-47.08%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
1
- -
1
2024
- -
1
1
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.01
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Kim Boyce
Full Time Employees
7
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
1266 South 1380 West Orem UT United States of America 84058
IPO Date
May 1, 2007
Business
Reflect Scientific, Inc. (OTCIQ: RSCF) designs, develops, and sells scientific equipment for the life sciences and manufacturing industries worldwide. The company, founded in 1993 and headquartered in Orem, Utah, offers Cryometrix ultra-low temperature freezers, blast freezers, and ethanol chilling systems based on proprietary liquid nitrogen technology serving biotechnology, pharmaceutical, medical, extraction, and transportation markets; laboratory consumables including ferrules, inlet liners, custom vial kits, and septa through GCFerrules; and OEM chromatography products such as filtration, purification items, customized sample handling vials, electronic wiring assemblies, high temperature silicone, and graphite sealing components via Visacon; as well as solvent chillers and refrigerated transportation solutions. Reflect Scientific operates primarily in the United States with global customer reach encompassing hospitals, diagnostic laboratories, pharmaceutical and biotech firms, universities, governments, cold chain management providers, and industrial entities. In 2024, the company reports strong revenue growth driven by demand for Cryometrix freezers and solvent chillers, secures a $550,000 sale of multiple freezer systems to a major biopharmaceutical client with shipments in Q1-Q2, announces over $1 million in follow-on orders for its B-90 blast freezer, and launches a strategic cost-cutting initiative leveraging AI and manufacturing partnerships to reduce SG&A expenses by up to 35% in 2025.

Company News

APIChat
  • Reflect Scientific Completes $550,000 Next-Generation Freezer Installation for Pharmaceutical Client

  • Reflect Scientific, Inc. Receives over $250,000 in New Orders for High-Performance Freezers from International Biotech and Pharma Clients

  • Reflect Scientific Receives Over $250,000 in New Orders for High-Performance Freezers from International Biotech and Pharma Clients

  • Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic Innovation

  • Reflect Scientific Inc. Announces Strategic Market Transition and Substantial Cost Savings

  • Reflect Scientific Inc. Reports Strong Revenue Growth in 2024

  • Reflect Scientific Inc. Secures $225,000 Order for Cutting-Edge Freezer Systems

  • Reflect Scientific Inc. Announces Second Quarter Sale of Groundbreaking Aerospace Manufacturing Solution

  • Reflect Scientific Inc. Announces Successful Testing of Liquid Nitrogen Temperature Control Technology

  • Reflect Scientific Inc. Announces Record-Breaking Freezer Order from a $40B BioPharma Company

  • Reflect Scientific Secures $200,000 Order from Prominent Bio-Pharma Client for Blast Freezers

  • Cryometrix Rapid Deployment Low-Temperature Chest Freezer for Vaccines